Zimbabwe Pharmaceuticals & Healthcare Q4 2006

Published by: Business Monitor International

Published: Dec. 1, 2006 - 53 Pages

Table of Contents

Chapter 1 - Executive Summary

Zimbabwe Pharmaceuticals & Healthcare Industry SWOT

Zimbabwe Economic SWOT

Zimbabwe Business Environment SWOT

Zimbabwe: Business Environment Ranking

Table: Business Environment Ranking: Middle East & Africa

Business Environment Ranking

Economics - Long-term Risk

Politics - Long-term Risk

Regulatory Barriers

Domestic Sector Threat

Market Growth Potential

Market Size Ranking

Chapter 2 - Zimbabwe: Market

Chapter 3 - Regulatory Regime

Intellectual Property Developments

Pricing and Reimbursement Issues

Chapter 4 - Industry Developments

Healthcare Sector Developments

Table: Key Health Indicators (WHO)

HIV/AIDS Crisis

Pharmaceutical Sector Developments

Impact of Foreign Currency Shortages

Plans To Establish New Pharmaceutical Concern

Chapter 5 - Industry Forecast Scenario

Key Growth Factors - Industry

Table: Zimbabwe Pharmaceuticals Sector - Historical Data & Forecasts

Key Growth Factors -Macroeconomic

Table: Economic Activity

Prescription Market Forecast

Table: Prescription Drug Market Forecast

OTC Market Forecast

Table: OTC Market Forecast

Generics Market Forecast

Table: Generics Market Forecast

Export / Import Forecasts

Table: Import / Domestic Market Forecast

Other Healthcare Data Forecasts

Table: Other Healthcare forecast

Chapter 6 - Country Snapshot: Zimbabwe Demographic Data

Section 1: Population:

Table: Demographic Indicators (2005)

Table: Rural/Urban Breakdown

Zimbabwe Pharmaceuticals & Healthcare Report Q3 2006

Section 2: Education & Healthcare

Table: Education

Table: Healthcare: Vital Statistics

Table: Healthcare: Expenditure

Section 3: Labour Market And Spending Power

Table: Employment Indicators

Table: Wages per year

Chapter 7 - Company Monitor

Ranbaxy

Datlabs

Varichem Laboratories

Chapter 8 - BMI Forecast Modelling

How we generate our industry forecasts

Technical Process

Pharmaceutical Industry

Chapter 9 - Appendix: Regional Demographic Data

The Long View: Data Over The Economic Cycle (2000-2007)

Population

Household Spending Per Capita, US$

Private Consumption Per Capita, US$ PPP

Market Size, GDP, US$bn

Abstract

The value of the Zimbabwean drug market has fallen dramatically since the mid-nineties and is now negligible. The collapse of the Zimbabwean dollar, the economic consequences of government policy and deteriorating relations with the international community has made Zimbabwe an extremely difficult location for drug manufacturers. Inflation is running at over 1,000% per year, while drug prices have increased by 1,376% since January 2005.

Local drugmakers must rely on exports in order to generate enough foreign currency to survive. Domestic drugmaker CAPS Holdings, for example, sells drugs in a wide range of African markets. However, the company has recently lost its partner - Indian generics maker Shreya - in a local joint venture. Shreya is one of India's leading ARV producers and its exit from the Zimbabwe, which has one of the highest HIV/AIDS caseloads in the world, is indicative of the challenging circumstances for even the most resilient of companies.

BMI's adjusted Business Environment Rankings for the Middle East & Africa reveal that Zimbabwe is in 14th place. This is primarily due to the country's dismal long term political and economic environment. Rampant inflation and shortages of foreign currency has made domestic production difficult. Counterfeits are a major problem, and the situation is becoming even more severe as medicines are unaffordable for much of the population. Endemic corruption both in the health service and among government officials has also helped create a burgeoning black market.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.